IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 153 filers reported holding IMMUNOGEN INC in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $317,400 | +0.0% | 20,000 | +18.9% | 0.00% | – |
Q2 2023 | $317,374 | -80.0% | 16,819 | -94.0% | 0.00% | -100.0% |
Q3 2021 | $1,587,000 | +979.6% | 279,963 | +872.6% | 0.00% | – |
Q4 2019 | $147,000 | +359.4% | 28,786 | +119.3% | 0.00% | – |
Q3 2019 | $32,000 | +3.2% | 13,124 | -8.2% | 0.00% | – |
Q2 2019 | $31,000 | -83.7% | 14,297 | -79.6% | 0.00% | -100.0% |
Q1 2019 | $190,000 | +8.6% | 70,234 | +92.4% | 0.00% | 0.0% |
Q4 2018 | $175,000 | -23.6% | 36,498 | +50.8% | 0.00% | 0.0% |
Q3 2018 | $229,000 | -2.6% | 24,200 | +0.1% | 0.00% | 0.0% |
Q2 2018 | $235,000 | +78.0% | 24,181 | +92.0% | 0.00% | 0.0% |
Q1 2018 | $132,000 | +15.8% | 12,592 | -29.1% | 0.00% | – |
Q4 2017 | $114,000 | -58.2% | 17,750 | -50.3% | 0.00% | -100.0% |
Q3 2017 | $273,000 | +111.6% | 35,750 | +97.4% | 0.00% | 0.0% |
Q2 2017 | $129,000 | -37.7% | 18,112 | -66.1% | 0.00% | 0.0% |
Q1 2017 | $207,000 | +314.0% | 53,444 | +116.4% | 0.00% | – |
Q4 2016 | $50,000 | -31.5% | 24,700 | -9.9% | 0.00% | – |
Q3 2016 | $73,000 | +30.4% | 27,418 | +50.0% | 0.00% | – |
Q2 2016 | $56,000 | -62.7% | 18,276 | +3.8% | 0.00% | -100.0% |
Q1 2016 | $150,000 | -32.7% | 17,605 | +7.0% | 0.00% | -50.0% |
Q4 2015 | $223,000 | +32.0% | 16,447 | -6.6% | 0.00% | +100.0% |
Q3 2015 | $169,000 | -21.4% | 17,615 | +18.1% | 0.00% | -50.0% |
Q2 2015 | $215,000 | +68.0% | 14,919 | +4.3% | 0.00% | +100.0% |
Q1 2015 | $128,000 | +48.8% | 14,300 | -5.6% | 0.00% | 0.0% |
Q4 2014 | $86,000 | -42.7% | 15,155 | +0.5% | 0.00% | -50.0% |
Q3 2014 | $150,000 | -6.2% | 15,076 | +11.7% | 0.00% | 0.0% |
Q2 2014 | $160,000 | -17.9% | 13,500 | +3.6% | 0.00% | -33.3% |
Q1 2014 | $195,000 | -15.9% | 13,029 | -17.5% | 0.00% | -25.0% |
Q4 2013 | $232,000 | +383.3% | 15,800 | +457.7% | 0.00% | +300.0% |
Q3 2013 | $48,000 | +2.1% | 2,833 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $47,000 | – | 2,833 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |